Phase I NT-501 Ciliary Neurotrophic Factor Implant Trial for Primary Open-Angle Glaucoma: Safety, Neuroprotection, and Neuroenhancement

PURPOSE: To assess the safety and efficacy of a ciliary neurotrophic factor (CNTF) intraocular implant on neuroprotection and neuroenhancement in glaucoma. DESIGN: Open-label, prospective, phase I clinical trial. PARTICIPANTS: A total of 11 participants were diagnosed with primary open-angle glaucom...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberg, Jeffrey L., Beykin, Gala, Satterfield, Kellie R., Nuñez, Mariana, Lam, Byron L., Albini, Thomas A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Neuroprotection, Neuroenhancement, and Neuroregeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183667/
https://www.ncbi.nlm.nih.gov/pubmed/37197702
http://dx.doi.org/10.1016/j.xops.2023.100298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183667/
https://www.ncbi.nlm.nih.gov/pubmed/37197702
http://dx.doi.org/10.1016/j.xops.2023.100298

Ejemplares similares